✦ LIBER ✦

CURRENT ROLE OF GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION AFTER PRETREATMENT WITH LOADING DOSE THIENOPYRIDINES: INSIGHTS FROM RANDOMIZED TRIALS

✍ Scribed by Feng Zhang; Juying Qian; Junbo Ge

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GLYCOPROTEIN IIB/IIIA INHIBITORS WITH UP

✍ Ankur Sethi; Anurag Bajaj; Amol Bahekar; Rohit Bhuriya; Param Singh; Mukesh Sing 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

DO WE STILL NEED A GLYCOPROTEIN IIB/IIIA

✍ Lili Dong; Yongshi Wang; Xianhong Shu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

UPSTREAM VERSUS DEFERRED ADMINISTRATION

✍ Lili Dong; Feng Zhang; Xianhong Shu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

AS-77: Clinical Benefits of Glycoprotein

✍ Doo Sun Sim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Procedural Glycoprotein IIb/IIIa inhibit

✍ Michael Mok; Alexander J. Black; David Clark; Andrew E. Ajani; Stephen J. Duffy; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Timing of Glycoprotein IIb/IIIa Inhibito

✍ Pierluigi Tricoci; Eric D. Peterson; Anita Y. Chen; L. Kristin Newby; Robert A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB